- Home
- KMDA vs BARK Comparison
KMDA vs BARK Comparison
Compare KMDA & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- BARK
- Stock Information
- Founded
- KMDA 1990
- BARK 2011
- Country
- KMDA Israel
- BARK United States
- Employees
- KMDA N/A
- BARK N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- BARK Department/Specialty Retail Stores
- Sector
- KMDA Health Care
- BARK Consumer Discretionary
- Exchange
- KMDA Nasdaq
- BARK Nasdaq
- Market Cap
- KMDA 349.6M
- BARK 342.7M
- IPO Year
- KMDA N/A
- BARK N/A
- Fundamental
- Price
- KMDA $7.16
- BARK $2.00
- Analyst Decision
- KMDA Strong Buy
- BARK Strong Buy
- Analyst Count
- KMDA 2
- BARK 3
- Target Price
- KMDA $14.50
- BARK $2.30
- AVG Volume (30 Days)
- KMDA 142.0K
- BARK 1.2M
- Earning Date
- KMDA 03-05-2025
- BARK 02-05-2025
- Dividend Yield
- KMDA N/A
- BARK N/A
- EPS Growth
- KMDA 124.29
- BARK N/A
- EPS
- KMDA 0.27
- BARK N/A
- Revenue
- KMDA $158,380,000.00
- BARK $488,881,000.00
- Revenue This Year
- KMDA $15.81
- BARK $3.23
- Revenue Next Year
- KMDA $5.79
- BARK $10.01
- P/E Ratio
- KMDA $26.36
- BARK N/A
- Revenue Growth
- KMDA 4.52
- BARK N/A
- 52 Week Low
- KMDA $4.74
- BARK $0.86
- 52 Week High
- KMDA $8.00
- BARK $2.56
- Technical
- Relative Strength Index (RSI)
- KMDA 70.04
- BARK 50.15
- Support Level
- KMDA $7.00
- BARK $1.73
- Resistance Level
- KMDA $8.00
- BARK $2.10
- Average True Range (ATR)
- KMDA 0.31
- BARK 0.15
- MACD
- KMDA 0.06
- BARK -0.01
- Stochastic Oscillator
- KMDA 60.93
- BARK 45.30
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.